In a perfect democracy, at least 50% of people would support every decision.

The U.S. falls short of this goal.

Activate to continue

Spoken For.
House vote: H.R. 5247 // March 21, 2018

Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018

Sponsor: Brian Fitzpatrick (R-PA)

Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018 This bill amends the Federal Food, Drug, and Cosmetic Act to exempt, from specified requirements and restrictions under that Act and other laws, the provision of certain unapproved, investigational drugs to a terminally ill patient who has exhausted approved treatment options and is unable to participate in a clinical trial involving the drugs. The manufacturer or sponsor of an eligible investigational drug must publish annual summaries on any use of the drug in accordance with these provisions. The bill limits the liability of a sponsor, manufacturer, licensed physician, clinical investigator, or hospital that provides, or declines to provide, an eligible investigational drug to an eligible patient in accordance with the bill.

Health Topic assigned by the Congressional Research Service.

Who won, and how much of the country was behind them

Won the vote · Yea

267 votes, representing 155,163,284 people61.3%of U.S. adults

Lost the vote · Nay

149 votes, representing 87,075,387 people34.4%of U.S. adults

The dotted gap is 4.3% of U.S. adults whose member did not vote, voted “present,” or whose seat was vacant.

Share of U.S. adults represented, the House
SideOutcomeVotesShare of U.S. adults
YeaWon26761.3%
NayLost14934.4%
Not represented on this questionNo position taken04.3%